Related Experiment Videos

Effect of phenobarbitone administration to pregnant rats on anxiety in offsprings

K P Singh1, M Singh, A K Jaiswal

  • 1Department of Anatomy, Banaras Hindu University, Varanasi, India.

Insights

Prenatal exposure to phenobarbitone in rats resulted in lasting anxiety-like behaviors. Offspring showed increased exploration and fear responses, indicating developmental neurotoxicity.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Prenatal exposure to certain medications can impact offspring neurodevelopment.
  • Phenobarbitone is a commonly used sedative and anticonvulsant with potential developmental effects.
  • Understanding the long-term behavioral consequences of prenatal drug exposure is crucial.

Purpose of the Study:

  • To investigate the long-term effects of prenatal phenobarbitone exposure on anxiety-like behaviors in adult rats.
  • To assess the impact of phenobarbitone during critical neural development periods.

Main Methods:

  • Pregnant rats were administered phenobarbitone (10 mg/kg, i.p.) or vehicle from gestational day 13 to 21.
  • Offspring were evaluated at 8-9 weeks of age using behavioral tests: open-field, elevated plus-maze, and elevated zero-maze.
  • Behavioral parameters included ambulation, rearing, self-grooming, fecal droppings, time on arms, and head dips.

Main Results:

  • Prenatal phenobarbitone exposure led to significantly increased ambulation and rearing in the open-field test.
  • Offspring spent less time on open arms and more time/entries in enclosed arms of the elevated plus-maze.
  • Reduced time on open arms, fewer head dips, and stretched-attend postures were observed in the elevated zero-maze, indicating increased anxiety.

Conclusions:

  • Prenatal phenobarbitone exposure induces persistent anxiety-like behaviors in adult rat offspring.
  • This suggests phenobarbitone can disrupt normal neural development, leading to long-term behavioral alterations.
  • The findings highlight potential risks associated with maternal phenobarbitone use during pregnancy.

Related Concept Videos